What is Neurogene Inc (NGNE) stock price today?

Neurogene Inc (NGNE) currently trades at $26.48 per share. The stock has a market capitalization of $422.41M and a P/E ratio of —x.

Is NGNE stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Neurogene Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

NGNE

Neurogene Inc

NASDAQ: NGNE · HEALTHCARE · BIOTECHNOLOGY

$26.48

-3.53% today

Updated 2026-04-29

Market cap

$422.41M

P/E ratio

—

P/S ratio

438.73x

EPS (TTM)

$-4.24

Dividend yield

—

52W range

$12 – $37

Volume

0.2M

Market cap

$422.41M

P/E ratio

—

P/S ratio

438.73x

EPS (TTM)

$-4.24

Dividend yield

—

52W range

$12 – $37

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$77.67

+193.32%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-16.79M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$925000.00	$0.00	$0.00
Net income	$-55.19M	$-36.32M	$-75.14M	$-90.35M	$-24.73M
EPS	—	—	—	—	$-4.24
Free cash flow	$-55.05M	$-51.74M	$-71.41M	$-78.36M	$-16.79M
Profit margin	—	—	-8,123.68%	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NGNE	$422.41M	31	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Neurogene Inc trades at $26.48. Our Smart Value Score of 31/100 indicates the stock is weak.

Frequently asked questions

What is Neurogene Inc's stock price?

Neurogene Inc (NGNE) trades at $26.48.

Is Neurogene Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Neurogene Inc (NGNE)?

The analyst target price is $77.67, representing +193.3% upside from the current price of $26.48.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio438.73x

ROE-31.40%

Beta1.89

50D MA$21.69

200D MA$21.73

Shares out0.02B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week-2.56%

1 month+32.83%

3 months+41.37%

YTD+31.21%

1 year—

3 years—

5 years—

Compare

NGNE vs LLY →NGNE vs JNJ →NGNE vs ABBV →Stock screener →